Geode Capital Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.3M Buy
2,808,886
+127,951
+5% +$1.43M ﹤0.01% 1942
2026
Q1
$31.9M Buy
2,680,935
+53,629
+2% +$549K ﹤0.01% 1739
2025
Q4
$26.2M Buy
2,627,306
+19,998
+0.8% +$191K ﹤0.01% 1866
2025
Q3
$23.3M Buy
2,607,308
+144,425
+6% +$1.34M ﹤0.01% 1926
2025
Q2
$23.2M Sell
2,462,883
-103,099
-4% -$910K ﹤0.01% 1887
2025
Q1
$27.8M Buy
2,565,982
+98,213
+4% +$988K ﹤0.01% 1719
2024
Q4
$23.5M Buy
2,467,769
+16,596
+0.7% +$168K ﹤0.01% 1893
2024
Q3
$27.5M Buy
2,451,173
+265,712
+12% +$2.82M ﹤0.01% 1808
2024
Q2
$21.9M Buy
2,185,461
+131,548
+6% +$1.34M ﹤0.01% 1885
2024
Q1
$23.6M Buy
2,053,913
+51,221
+3% +$435K ﹤0.01% 1818
2023
Q4
$14.6M Buy
2,002,692
+94,414
+5% +$744K ﹤0.01% 2100
2023
Q3
$17.4M Buy
1,908,278
+327,710
+21% +$3.93M ﹤0.01% 1910
2023
Q2
$19.2M Buy
1,580,568
+51,721
+3% +$576K ﹤0.01% 1877
2023
Q1
$19M Buy
1,528,847
+48,504
+3% +$892K ﹤0.01% 1835
2022
Q4
$28.5M Buy
1,480,343
+34,452
+2% +$728K ﹤0.01% 1534
2022
Q3
$27.2M Sell
1,445,891
-158,089
-10% -$3.25M ﹤0.01% 1525
2022
Q2
$28.9M Buy
1,603,980
+91,560
+6% +$1.49M ﹤0.01% 1494
2022
Q1
$24.2M Sell
1,512,420
-8,079
-0.5% -$145K ﹤0.01% 1763
2021
Q4
$37.2M Buy
1,520,499
+26,877
+2% +$631K ﹤0.01% 1523
2021
Q3
$34.8M Sell
1,493,622
-110,206
-7% -$2.66M ﹤0.01% 1583
2021
Q2
$44M Buy
1,603,828
+281,037
+21% +$8.01M 0.01% 1415
2021
Q1
$48.6M Buy
1,322,791
+734,956
+125% +$26M 0.01% 1256
2020
Q4
$22.1M Buy
587,835
+103,841
+21% +$3.21M ﹤0.01% 1660
2020
Q3
$10.6M Buy
483,994
+395,356
+446% +$8.3M ﹤0.01% 1908
2020
Q2
$1.43M Buy
+88,638
New +$1.48M ﹤0.01% 3017
2019
Q1
Sell
-449,999
Closed -$4.32M 4128
2018
Q4
$4.32M Hold
449,999
﹤0.01% 2306
2018
Q3
$4.32M Buy
449,999
+200,000
+80% +$1.94M ﹤0.01% 2443
2018
Q2
$2.41M Buy
+249,999
New +$2.43M ﹤0.01% 2749

Other funds holding AHCO

Geode Capital Management's AHCO Position: Q2 2026 in Review

Geode Capital Management increased its AdaptHealth (AHCO) stake by 4.8% in Q2 2026, buying an estimated $1.43M and bringing the position to 2,808,886 shares worth $29.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1942.

Geode Capital Management first reported a position in AHCO in Q2 2018 and has held it in 28 quarters since. The position peaked at $48.6M in Q1 2021. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Geode Capital Management held 2,808,886 shares of AdaptHealth worth $29.3M as of Q2 2026.
  • Geode Capital Management bought 127,951 AdaptHealth shares in Q2 2026, an estimated $1.43M.
  • AdaptHealth made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #1942 holding.
  • Geode Capital Management first reported a position in AdaptHealth in Q2 2018 and has held it in 28 quarters since.
  • Geode Capital Management's AdaptHealth position peaked at $48.6M in Q1 2021.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.